Maria Y. Giovanni
Assistant Director for Microbial Genomics & Advanced Technology
Investigators interested in requesting DNA sequencing, assembly, primary annotation, and analysis of a specific microorganism, group of microorganisms, or an invertebrate vector of infectious disease must submit a "white paper" (MS Word) to NIAID for consideration.
NIAID will only accept and review white papers to sequence microorganisms or their invertebrate vector of infectious diseases that are considered agents of bioterrorism or cause emerging or re-emerging infectious diseases and related strains or species. Comparative genomics sequencing projects are encouraged that are not hypothesis driven projects, predominately DNA sequencing and generate genomic data for the broad scientific community.
Investigators wishing to apply for support to sequence an organism not described above must do so in the context of an investigator-initiated, hypothesis-driven, unsolicited research project application (R01), subject to standard National Institutes of Health acceptance and peer-review procedures. NIAID will only accept such applications for review that contain a substantial research component beyond genome sequencing.
NIAID will not accept unsolicited grant applications for large-scale DNA sequencing projects for microorganisms and invertebrate vectors of disease, including NIH cooperative agreement grant applications, which is a change in NIAID policy, effective December 2003.
To access services from the Influenza Genome Sequencing Project, a proposal (MS Word) describing the viruses to be sequenced should be submitted to NIAID for review and approval. Completed proposal forms can be faxed to 301-480-4528 or emailed to Maria Y. Giovanni, firstname.lastname@example.org and Punam Mathur, email@example.com.
Last Updated December 06, 2012